Clinical isolates of Streptococcus mitis/oralis -related species with reduced carbapenem susceptibility, harboring amino acid substitutions in penicillin-binding proteins in Japan

Jayathilake Sarangi,Ayaka Ido,Masaya Ito,Chihiro Iinuma,Yo Doyama,Wanchun Jin,Jun-Ichi Wachino,Masahiro Suzuki,Mitsutaka Iguchi,Tetsuya Yagi,Yoshichika Arakawa,Kouji Kimura,Jun-ichi Wachino
DOI: https://doi.org/10.1128/aac.01179-23
IF: 5.938
2024-02-28
Antimicrobial Agents and Chemotherapy
Abstract:ABSTRACT Streptococcus mitis/oralis group isolates with reduced carbapenem susceptibility have been reported, but its isolation rate in Japan is unknown. We collected 356 clinical α-hemolytic streptococcal isolates and identified 142 of them as S. mitis/oralis using partial sodA sequencing. The rate of meropenem non-susceptibility was 17.6% (25/142). All 25 carbapenem-non-susceptible isolates harbored amino acid substitutions in/near the conserved motifs in PBP1A, PBP2B, and PBP2X. Carbapenem non-susceptibility is common among S. mitis/oralis group isolates in Japan.
pharmacology & pharmacy,microbiology
What problem does this paper attempt to address?